Rhumbline Advisers lifted its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report) by 3.5% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 53,256 shares of the company’s stock after buying an additional 1,794 shares during the quarter. Rhumbline Advisers’ holdings in U.S. Physical Therapy were worth $3,854,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Portside Wealth Group LLC grew its position in shares of U.S. Physical Therapy by 3.9% during the first quarter. Portside Wealth Group LLC now owns 4,108 shares of the company’s stock worth $297,000 after buying an additional 154 shares in the last quarter. Precision Wealth Strategies LLC boosted its holdings in U.S. Physical Therapy by 6.6% in the first quarter. Precision Wealth Strategies LLC now owns 3,054 shares of the company’s stock valued at $221,000 after purchasing an additional 189 shares in the last quarter. Bessemer Group Inc. boosted its holdings in U.S. Physical Therapy by 4.4% in the first quarter. Bessemer Group Inc. now owns 4,929 shares of the company’s stock valued at $357,000 after purchasing an additional 208 shares in the last quarter. Comerica Bank boosted its holdings in U.S. Physical Therapy by 3.0% in the first quarter. Comerica Bank now owns 8,181 shares of the company’s stock valued at $592,000 after purchasing an additional 237 shares in the last quarter. Finally, Albert D Mason Inc. boosted its holdings in U.S. Physical Therapy by 2.5% in the first quarter. Albert D Mason Inc. now owns 10,856 shares of the company’s stock valued at $786,000 after purchasing an additional 260 shares in the last quarter.
Get U.S. Physical Therapy alerts:
Insider Activity
In related news, Director Nancy Ham sold 600 shares of the company’s stock in a transaction on Thursday, September 11th. The stock was sold at an average price of $81.71, for a total transaction of $49,026.00. Following the transaction, the director owned 1,994 shares of the company’s stock, valued at $162,929.74. This represents a 23.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Eric Joseph Williams sold 1,000 shares of the company’s stock in a transaction on Friday, September 5th. The stock was sold at an average price of $85.25, for a total value of $85,250.00. Following the transaction, the chief operating officer directly owned 25,331 shares in the company, valued at $2,159,467.75. This represents a 3.80% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 6,853 shares of company stock valued at $581,406 over the last three months. 2.00% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
A number of equities analysts recently issued reports on the company. Wall Street Zen raised U.S. Physical Therapy from a “hold” rating to a “buy” rating in a report on Saturday. Barrington Research upped their price target on U.S. Physical Therapy from $98.00 to $103.00 and gave the company an “outperform” rating in a report on Friday, August 8th. Finally, Zacks Research raised U.S. Physical Therapy to a “hold” rating in a report on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $110.25.
View Our Latest Analysis on USPH
U.S. Physical Therapy Price Performance
U.S. Physical Therapy stock opened at $80.66 on Monday. U.S. Physical Therapy, Inc. has a 12 month low of $62.77 and a 12 month high of $101.19. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.18 and a quick ratio of 1.18. The business has a 50 day simple moving average of $79.97 and a 200-day simple moving average of $76.46. The stock has a market capitalization of $1.23 billion, a PE ratio of 35.22, a price-to-earnings-growth ratio of 4.02 and a beta of 1.47.
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported $0.81 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.10. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.The firm had revenue of $197.34 million for the quarter, compared to analyst estimates of $190.24 million. During the same quarter in the prior year, the company posted $0.73 earnings per share. U.S. Physical Therapy’s quarterly revenue was up 18.0% on a year-over-year basis. Equities analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.
U.S. Physical Therapy Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 12th. Investors of record on Friday, August 22nd were issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend was Friday, August 22nd. U.S. Physical Therapy’s dividend payout ratio is currently 78.60%.
U.S. Physical Therapy Company Profile
(Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
See Also
Five stocks we like better than U.S. Physical Therapy
Investing in Construction Stocks
Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside
3 REITs to Buy and Hold for the Long Term
Football Season Is Here and DraftKings Stock Is Surging
What Are Growth Stocks and Investing in Them
RH Stock Slides After Mixed Earnings and Tariff Concerns
Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report).